Caterpillar Inc. (BVMF:CATP34)
Brazil · Delayed Price · Currency is BRL 144.87
-1.29 (-0.88%)
At close: Aug 7, 2025, 4:55 PM GMT-3
Revance Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 9,437 | 10,792 | 10,335 | 6,705 | 6,489 | 2,998 | Upgrade |
Depreciation & Amortization | 2,122 | 2,083 | 2,144 | 2,219 | 2,352 | 2,432 | Upgrade |
Loss (Gain) From Sale of Assets | - | 164 | 572 | - | - | - | Upgrade |
Asset Writedown & Restructuring Costs | 70 | 70 | - | 925 | - | - | Upgrade |
Other Operating Activities | 103 | -215 | -317 | -283 | -996 | 1,314 | Upgrade |
Change in Accounts Receivable | -234 | -160 | -437 | -220 | -1,259 | 1,442 | Upgrade |
Change in Inventory | -1,410 | -414 | -364 | -2,589 | -2,586 | -34 | Upgrade |
Change in Accounts Payable | 712 | -282 | -754 | 798 | 2,041 | 98 | Upgrade |
Change in Unearned Revenue | 1,305 | 370 | 80 | 768 | 34 | -126 | Upgrade |
Change in Other Net Operating Assets | -732 | -373 | 1,626 | -557 | 1,123 | -1,797 | Upgrade |
Operating Cash Flow | 11,373 | 12,035 | 12,885 | 7,766 | 7,198 | 6,327 | Upgrade |
Operating Cash Flow Growth | -13.42% | -6.60% | 65.92% | 7.89% | 13.77% | -8.46% | Upgrade |
Capital Expenditures | -3,633 | -3,215 | -3,092 | -2,599 | -2,472 | -2,115 | Upgrade |
Sale of Property, Plant & Equipment | 745 | 722 | 781 | 830 | 1,265 | 772 | Upgrade |
Divestitures | 12 | -61 | -4 | 1 | 36 | 25 | Upgrade |
Investment in Securities | 296 | 1,626 | -2,589 | -782 | -1,471 | -404 | Upgrade |
Other Investing Activities | 83 | 193 | 97 | 14 | 79 | -66 | Upgrade |
Investing Cash Flow | -4,196 | -2,453 | -5,871 | -2,541 | -3,084 | -1,485 | Upgrade |
Short-Term Debt Issued | - | - | - | 402 | 3,488 | - | Upgrade |
Long-Term Debt Issued | - | 10,283 | 8,257 | 6,674 | 6,989 | 10,431 | Upgrade |
Total Debt Issued | 11,224 | 10,283 | 8,257 | 7,076 | 10,477 | 10,431 | Upgrade |
Short-Term Debt Repaid | - | -168 | -1,345 | - | - | -2,804 | Upgrade |
Long-Term Debt Repaid | - | -9,316 | -6,318 | -7,728 | -9,796 | -8,237 | Upgrade |
Total Debt Repaid | -8,435 | -9,484 | -7,663 | -7,728 | -9,796 | -11,041 | Upgrade |
Net Debt Issued (Repaid) | 2,789 | 799 | 594 | -652 | 681 | -610 | Upgrade |
Issuance of Common Stock | 12 | 20 | 12 | 51 | 135 | 229 | Upgrade |
Repurchase of Common Stock | -5,950 | -7,737 | -4,975 | -4,230 | -2,668 | -1,130 | Upgrade |
Common Dividends Paid | -2,699 | -2,646 | -2,563 | -2,440 | -2,332 | -2,243 | Upgrade |
Other Financing Activities | -133 | -1 | - | -10 | -4 | -1 | Upgrade |
Financing Cash Flow | -5,981 | -9,565 | -6,932 | -7,281 | -4,188 | -3,755 | Upgrade |
Foreign Exchange Rate Adjustments | -96 | -106 | -110 | -194 | -29 | -13 | Upgrade |
Net Cash Flow | 1,100 | -89 | -28 | -2,250 | -103 | 1,074 | Upgrade |
Free Cash Flow | 7,740 | 8,820 | 9,793 | 5,167 | 4,726 | 4,212 | Upgrade |
Free Cash Flow Growth | -22.95% | -9.94% | 89.53% | 9.33% | 12.20% | -0.73% | Upgrade |
Free Cash Flow Margin | 12.26% | 13.61% | 14.60% | 8.70% | 9.27% | 10.09% | Upgrade |
Free Cash Flow Per Share | 16.13 | 18.02 | 19.07 | 9.74 | 8.62 | 7.68 | Upgrade |
Cash Interest Paid | 1,738 | 1,738 | 1,435 | 959 | 920 | 1,089 | Upgrade |
Cash Income Tax Paid | 3,126 | 3,126 | 2,949 | 3,076 | 1,759 | 1,311 | Upgrade |
Levered Free Cash Flow | 4,528 | 5,220 | 8,563 | 3,576 | 7,036 | 2,169 | Upgrade |
Unlevered Free Cash Flow | 4,855 | 5,540 | 8,883 | 3,853 | 7,341 | 2,490 | Upgrade |
Change in Net Working Capital | 1,327 | 2,028 | -1,080 | 2,058 | -2,090 | 1,051 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.